Ravgen Fetal DNA Testing Patent Survives PTAB Review
The Patent Trial and Appeal Board has refused to invalidate a host of claims in a Ravgen Inc. prenatal genetic test patent, marking the latest win for the small biotech company...To view the full article, register now.
Already a subscriber? Click here to view full article